Mesto nizkodozovykh fiksirovannykh kombinatsiy antigipertenzivnykh preparatov u patsientov s arterial'noy gipertoniey
- Authors: Ratova LG1, Chazova IE1
-
Affiliations:
- Issue: Vol 5, No 4 (2008)
- Pages: 12-14
- Section: Articles
- URL: https://journals.eco-vector.com/2075-082X/article/view/28822
- DOI: https://doi.org/10.26442/SG28822
- ID: 28822
Cite item
Full Text
Abstract
References
- Диагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. 2008; Прил. 2.
- Kaplan N, Opie LH. Antihypertensive drugs. Ed.: L.Opie, Drugs for the heart, 4th ed. Philadelphia: W.B. Saunders, 1995.
- Frishman WH, Bryzinski BS, Coulson LR et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994; 154 (13): 1461-8.
- Frishman WH, Burris JF, Mroczek WJ et al. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol 1995; 35 (2): 182-8.
- Prisant LM, Neutel JM, Papademetriou V et al. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies. Am J Ther 1998; 5: 313-21.
- Benetos A, Adamopoulos C, Argyriadis P et al. Clinical results with bisoprolol 2,5 mg/hydrochlorothiazide 6,25 mg combination in systolic hypertension in the elderly. Hypertens Suppl 2002; 20 (1): 21-5.